Global RNAi Technology Market Growth (Status and Outlook) 2025-2031

September 2025 | 86 pages | ID: GEE381779678EN
LP Information

Abstracts

According to this study, the global RNAi Technology market size will reach US$ million by 2031.

RNA interference is a relatively new concept in the field of medicine. It is a process in which the ribonucleic acid inhibits translation or gene expression by converting single-stranded mRNA to double stranded RNA, thereby neutralizing the target nucleic acids.

As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.97%, including software, hardware and services.

LPI (LP Information)' newest research report, the “RNAi Technology Industry Forecast” looks at past sales and reviews total world RNAi Technology sales in 2024, providing a comprehensive analysis by region and market sector of projected RNAi Technology sales for 2025 through 2031. With RNAi Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNAi Technology industry.

This Insight Report provides a comprehensive analysis of the global RNAi Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on RNAi Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNAi Technology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNAi Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNAi Technology.

This report presents a comprehensive overview, market shares, and growth opportunities of RNAi Technology market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Cancer
• Liver Disorders
• Respiratory Disorders
• Neurological Disorders
• Autoimmune Disorders
• Others

Segmentation by Application:

• Drug Discovery & Development
• Therapeutics
• Drug Delivery
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Alnylam Pharmaceuticals
• Dicerna Pharmaceuticals, Inc.
• Arrowhead Pharmaceuticals, Inc.
• Ionis Pharmaceuticals, Inc.
• Quark Pharmaceuticals, Inc.
• Arbutus Biopharma
• Benitec Biopharma
• Calando
• Silence Therapeutics
• Gotham Therapeutics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global RNAi Technology Market Size (2020-2031)
  2.1.2 RNAi Technology Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for RNAi Technology by Country/Region (2020, 2024 & 2031)
2.2 RNAi Technology Segment by Type
  2.2.1 Cancer
  2.2.2 Liver Disorders
  2.2.3 Respiratory Disorders
  2.2.4 Neurological Disorders
  2.2.5 Autoimmune Disorders
  2.2.6 Others
2.3 RNAi Technology Market Size by Type
  2.3.1 RNAi Technology Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global RNAi Technology Market Size Market Share by Type (2020-2025)
2.4 RNAi Technology Segment by Application
  2.4.1 Drug Discovery & Development
  2.4.2 Therapeutics
  2.4.3 Drug Delivery
  2.4.4 Others
2.5 RNAi Technology Market Size by Application
  2.5.1 RNAi Technology Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global RNAi Technology Market Size Market Share by Application (2020-2025)

3 RNAI TECHNOLOGY MARKET SIZE BY PLAYER

3.1 RNAi Technology Market Size Market Share by Player
  3.1.1 Global RNAi Technology Revenue by Player (2020-2025)
  3.1.2 Global RNAi Technology Revenue Market Share by Player (2020-2025)
3.2 Global RNAi Technology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RNAI TECHNOLOGY BY REGION

4.1 RNAi Technology Market Size by Region (2020-2025)
4.2 Global RNAi Technology Annual Revenue by Country/Region (2020-2025)
4.3 Americas RNAi Technology Market Size Growth (2020-2025)
4.4 APAC RNAi Technology Market Size Growth (2020-2025)
4.5 Europe RNAi Technology Market Size Growth (2020-2025)
4.6 Middle East & Africa RNAi Technology Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas RNAi Technology Market Size by Country (2020-2025)
5.2 Americas RNAi Technology Market Size by Type (2020-2025)
5.3 Americas RNAi Technology Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC RNAi Technology Market Size by Region (2020-2025)
6.2 APAC RNAi Technology Market Size by Type (2020-2025)
6.3 APAC RNAi Technology Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe RNAi Technology Market Size by Country (2020-2025)
7.2 Europe RNAi Technology Market Size by Type (2020-2025)
7.3 Europe RNAi Technology Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa RNAi Technology by Region (2020-2025)
8.2 Middle East & Africa RNAi Technology Market Size by Type (2020-2025)
8.3 Middle East & Africa RNAi Technology Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RNAI TECHNOLOGY MARKET FORECAST

10.1 Global RNAi Technology Forecast by Region (2026-2031)
  10.1.1 Global RNAi Technology Forecast by Region (2026-2031)
  10.1.2 Americas RNAi Technology Forecast
  10.1.3 APAC RNAi Technology Forecast
  10.1.4 Europe RNAi Technology Forecast
  10.1.5 Middle East & Africa RNAi Technology Forecast
10.2 Americas RNAi Technology Forecast by Country (2026-2031)
  10.2.1 United States Market RNAi Technology Forecast
  10.2.2 Canada Market RNAi Technology Forecast
  10.2.3 Mexico Market RNAi Technology Forecast
  10.2.4 Brazil Market RNAi Technology Forecast
10.3 APAC RNAi Technology Forecast by Region (2026-2031)
  10.3.1 China RNAi Technology Market Forecast
  10.3.2 Japan Market RNAi Technology Forecast
  10.3.3 Korea Market RNAi Technology Forecast
  10.3.4 Southeast Asia Market RNAi Technology Forecast
  10.3.5 India Market RNAi Technology Forecast
  10.3.6 Australia Market RNAi Technology Forecast
10.4 Europe RNAi Technology Forecast by Country (2026-2031)
  10.4.1 Germany Market RNAi Technology Forecast
  10.4.2 France Market RNAi Technology Forecast
  10.4.3 UK Market RNAi Technology Forecast
  10.4.4 Italy Market RNAi Technology Forecast
  10.4.5 Russia Market RNAi Technology Forecast
10.5 Middle East & Africa RNAi Technology Forecast by Region (2026-2031)
  10.5.1 Egypt Market RNAi Technology Forecast
  10.5.2 South Africa Market RNAi Technology Forecast
  10.5.3 Israel Market RNAi Technology Forecast
  10.5.4 Turkey Market RNAi Technology Forecast
10.6 Global RNAi Technology Forecast by Type (2026-2031)
10.7 Global RNAi Technology Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market RNAi Technology Forecast

11 KEY PLAYERS ANALYSIS

11.1 Alnylam Pharmaceuticals
  11.1.1 Alnylam Pharmaceuticals Company Information
  11.1.2 Alnylam Pharmaceuticals RNAi Technology Product Offered
  11.1.3 Alnylam Pharmaceuticals RNAi Technology Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Alnylam Pharmaceuticals Main Business Overview
  11.1.5 Alnylam Pharmaceuticals Latest Developments
11.2 Dicerna Pharmaceuticals, Inc.
  11.2.1 Dicerna Pharmaceuticals, Inc. Company Information
  11.2.2 Dicerna Pharmaceuticals, Inc. RNAi Technology Product Offered
  11.2.3 Dicerna Pharmaceuticals, Inc. RNAi Technology Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Dicerna Pharmaceuticals, Inc. Main Business Overview
  11.2.5 Dicerna Pharmaceuticals, Inc. Latest Developments
11.3 Arrowhead Pharmaceuticals, Inc.
  11.3.1 Arrowhead Pharmaceuticals, Inc. Company Information
  11.3.2 Arrowhead Pharmaceuticals, Inc. RNAi Technology Product Offered
  11.3.3 Arrowhead Pharmaceuticals, Inc. RNAi Technology Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Arrowhead Pharmaceuticals, Inc. Main Business Overview
  11.3.5 Arrowhead Pharmaceuticals, Inc. Latest Developments
11.4 Ionis Pharmaceuticals, Inc.
  11.4.1 Ionis Pharmaceuticals, Inc. Company Information
  11.4.2 Ionis Pharmaceuticals, Inc. RNAi Technology Product Offered
  11.4.3 Ionis Pharmaceuticals, Inc. RNAi Technology Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Ionis Pharmaceuticals, Inc. Main Business Overview
  11.4.5 Ionis Pharmaceuticals, Inc. Latest Developments
11.5 Quark Pharmaceuticals, Inc.
  11.5.1 Quark Pharmaceuticals, Inc. Company Information
  11.5.2 Quark Pharmaceuticals, Inc. RNAi Technology Product Offered
  11.5.3 Quark Pharmaceuticals, Inc. RNAi Technology Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Quark Pharmaceuticals, Inc. Main Business Overview
  11.5.5 Quark Pharmaceuticals, Inc. Latest Developments
11.6 Arbutus Biopharma
  11.6.1 Arbutus Biopharma Company Information
  11.6.2 Arbutus Biopharma RNAi Technology Product Offered
  11.6.3 Arbutus Biopharma RNAi Technology Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Arbutus Biopharma Main Business Overview
  11.6.5 Arbutus Biopharma Latest Developments
11.7 Benitec Biopharma
  11.7.1 Benitec Biopharma Company Information
  11.7.2 Benitec Biopharma RNAi Technology Product Offered
  11.7.3 Benitec Biopharma RNAi Technology Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Benitec Biopharma Main Business Overview
  11.7.5 Benitec Biopharma Latest Developments
11.8 Calando
  11.8.1 Calando Company Information
  11.8.2 Calando RNAi Technology Product Offered
  11.8.3 Calando RNAi Technology Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Calando Main Business Overview
  11.8.5 Calando Latest Developments
11.9 Silence Therapeutics
  11.9.1 Silence Therapeutics Company Information
  11.9.2 Silence Therapeutics RNAi Technology Product Offered
  11.9.3 Silence Therapeutics RNAi Technology Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Silence Therapeutics Main Business Overview
  11.9.5 Silence Therapeutics Latest Developments
11.10 Gotham Therapeutics
  11.10.1 Gotham Therapeutics Company Information
  11.10.2 Gotham Therapeutics RNAi Technology Product Offered
  11.10.3 Gotham Therapeutics RNAi Technology Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Gotham Therapeutics Main Business Overview
  11.10.5 Gotham Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. RNAi Technology Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. RNAi Technology Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Cancer
Table 4. Major Players of Liver Disorders
Table 5. Major Players of Respiratory Disorders
Table 6. Major Players of Neurological Disorders
Table 7. Major Players of Autoimmune Disorders
Table 8. Major Players of Others
Table 9. RNAi Technology Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global RNAi Technology Market Size by Type (2020-2025) & ($ millions)
Table 11. Global RNAi Technology Market Size Market Share by Type (2020-2025)
Table 12. RNAi Technology Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global RNAi Technology Market Size by Application (2020-2025) & ($ millions)
Table 14. Global RNAi Technology Market Size Market Share by Application (2020-2025)
Table 15. Global RNAi Technology Revenue by Player (2020-2025) & ($ millions)
Table 16. Global RNAi Technology Revenue Market Share by Player (2020-2025)
Table 17. RNAi Technology Key Players Head office and Products Offered
Table 18. RNAi Technology Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global RNAi Technology Market Size by Region (2020-2025) & ($ millions)
Table 22. Global RNAi Technology Market Size Market Share by Region (2020-2025)
Table 23. Global RNAi Technology Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global RNAi Technology Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas RNAi Technology Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas RNAi Technology Market Size Market Share by Country (2020-2025)
Table 27. Americas RNAi Technology Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas RNAi Technology Market Size Market Share by Type (2020-2025)
Table 29. Americas RNAi Technology Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas RNAi Technology Market Size Market Share by Application (2020-2025)
Table 31. APAC RNAi Technology Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC RNAi Technology Market Size Market Share by Region (2020-2025)
Table 33. APAC RNAi Technology Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC RNAi Technology Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe RNAi Technology Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe RNAi Technology Market Size Market Share by Country (2020-2025)
Table 37. Europe RNAi Technology Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe RNAi Technology Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa RNAi Technology Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa RNAi Technology Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa RNAi Technology Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of RNAi Technology
Table 43. Key Market Challenges & Risks of RNAi Technology
Table 44. Key Industry Trends of RNAi Technology
Table 45. Global RNAi Technology Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global RNAi Technology Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global RNAi Technology Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global RNAi Technology Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Alnylam Pharmaceuticals Details, Company Type, RNAi Technology Area Served and Its Competitors
Table 50. Alnylam Pharmaceuticals RNAi Technology Product Offered
Table 51. Alnylam Pharmaceuticals RNAi Technology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Alnylam Pharmaceuticals Main Business
Table 53. Alnylam Pharmaceuticals Latest Developments
Table 54. Dicerna Pharmaceuticals, Inc. Details, Company Type, RNAi Technology Area Served and Its Competitors
Table 55. Dicerna Pharmaceuticals, Inc. RNAi Technology Product Offered
Table 56. Dicerna Pharmaceuticals, Inc. RNAi Technology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Dicerna Pharmaceuticals, Inc. Main Business
Table 58. Dicerna Pharmaceuticals, Inc. Latest Developments
Table 59. Arrowhead Pharmaceuticals, Inc. Details, Company Type, RNAi Technology Area Served and Its Competitors
Table 60. Arrowhead Pharmaceuticals, Inc. RNAi Technology Product Offered
Table 61. Arrowhead Pharmaceuticals, Inc. RNAi Technology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Arrowhead Pharmaceuticals, Inc. Main Business
Table 63. Arrowhead Pharmaceuticals, Inc. Latest Developments
Table 64. Ionis Pharmaceuticals, Inc. Details, Company Type, RNAi Technology Area Served and Its Competitors
Table 65. Ionis Pharmaceuticals, Inc. RNAi Technology Product Offered
Table 66. Ionis Pharmaceuticals, Inc. RNAi Technology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Ionis Pharmaceuticals, Inc. Main Business
Table 68. Ionis Pharmaceuticals, Inc. Latest Developments
Table 69. Quark Pharmaceuticals, Inc. Details, Company Type, RNAi Technology Area Served and Its Competitors
Table 70. Quark Pharmaceuticals, Inc. RNAi Technology Product Offered
Table 71. Quark Pharmaceuticals, Inc. RNAi Technology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Quark Pharmaceuticals, Inc. Main Business
Table 73. Quark Pharmaceuticals, Inc. Latest Developments
Table 74. Arbutus Biopharma Details, Company Type, RNAi Technology Area Served and Its Competitors
Table 75. Arbutus Biopharma RNAi Technology Product Offered
Table 76. Arbutus Biopharma RNAi Technology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Arbutus Biopharma Main Business
Table 78. Arbutus Biopharma Latest Developments
Table 79. Benitec Biopharma Details, Company Type, RNAi Technology Area Served and Its Competitors
Table 80. Benitec Biopharma RNAi Technology Product Offered
Table 81. Benitec Biopharma RNAi Technology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Benitec Biopharma Main Business
Table 83. Benitec Biopharma Latest Developments
Table 84. Calando Details, Company Type, RNAi Technology Area Served and Its Competitors
Table 85. Calando RNAi Technology Product Offered
Table 86. Calando RNAi Technology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Calando Main Business
Table 88. Calando Latest Developments
Table 89. Silence Therapeutics Details, Company Type, RNAi Technology Area Served and Its Competitors
Table 90. Silence Therapeutics RNAi Technology Product Offered
Table 91. Silence Therapeutics RNAi Technology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Silence Therapeutics Main Business
Table 93. Silence Therapeutics Latest Developments
Table 94. Gotham Therapeutics Details, Company Type, RNAi Technology Area Served and Its Competitors
Table 95. Gotham Therapeutics RNAi Technology Product Offered
Table 96. Gotham Therapeutics RNAi Technology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Gotham Therapeutics Main Business
Table 98. Gotham Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. RNAi Technology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNAi Technology Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. RNAi Technology Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. RNAi Technology Sales Market Share by Country/Region (2024)
Figure 8. RNAi Technology Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global RNAi Technology Market Size Market Share by Type in 2024
Figure 10. RNAi Technology in Drug Discovery & Development
Figure 11. Global RNAi Technology Market: Drug Discovery & Development (2020-2025) & ($ millions)
Figure 12. RNAi Technology in Therapeutics
Figure 13. Global RNAi Technology Market: Therapeutics (2020-2025) & ($ millions)
Figure 14. RNAi Technology in Drug Delivery
Figure 15. Global RNAi Technology Market: Drug Delivery (2020-2025) & ($ millions)
Figure 16. RNAi Technology in Others
Figure 17. Global RNAi Technology Market: Others (2020-2025) & ($ millions)
Figure 18. Global RNAi Technology Market Size Market Share by Application in 2024
Figure 19. Global RNAi Technology Revenue Market Share by Player in 2024
Figure 20. Global RNAi Technology Market Size Market Share by Region (2020-2025)
Figure 21. Americas RNAi Technology Market Size 2020-2025 ($ millions)
Figure 22. APAC RNAi Technology Market Size 2020-2025 ($ millions)
Figure 23. Europe RNAi Technology Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa RNAi Technology Market Size 2020-2025 ($ millions)
Figure 25. Americas RNAi Technology Value Market Share by Country in 2024
Figure 26. United States RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC RNAi Technology Market Size Market Share by Region in 2024
Figure 31. APAC RNAi Technology Market Size Market Share by Type (2020-2025)
Figure 32. APAC RNAi Technology Market Size Market Share by Application (2020-2025)
Figure 33. China RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 37. India RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe RNAi Technology Market Size Market Share by Country in 2024
Figure 40. Europe RNAi Technology Market Size Market Share by Type (2020-2025)
Figure 41. Europe RNAi Technology Market Size Market Share by Application (2020-2025)
Figure 42. Germany RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 43. France RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 44. UK RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa RNAi Technology Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa RNAi Technology Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa RNAi Technology Market Size Market Share by Application (2020-2025)
Figure 50. Egypt RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries RNAi Technology Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas RNAi Technology Market Size 2026-2031 ($ millions)
Figure 56. APAC RNAi Technology Market Size 2026-2031 ($ millions)
Figure 57. Europe RNAi Technology Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa RNAi Technology Market Size 2026-2031 ($ millions)
Figure 59. United States RNAi Technology Market Size 2026-2031 ($ millions)
Figure 60. Canada RNAi Technology Market Size 2026-2031 ($ millions)
Figure 61. Mexico RNAi Technology Market Size 2026-2031 ($ millions)
Figure 62. Brazil RNAi Technology Market Size 2026-2031 ($ millions)
Figure 63. China RNAi Technology Market Size 2026-2031 ($ millions)
Figure 64. Japan RNAi Technology Market Size 2026-2031 ($ millions)
Figure 65. Korea RNAi Technology Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia RNAi Technology Market Size 2026-2031 ($ millions)
Figure 67. India RNAi Technology Market Size 2026-2031 ($ millions)
Figure 68. Australia RNAi Technology Market Size 2026-2031 ($ millions)
Figure 69. Germany RNAi Technology Market Size 2026-2031 ($ millions)
Figure 70. France RNAi Technology Market Size 2026-2031 ($ millions)
Figure 71. UK RNAi Technology Market Size 2026-2031 ($ millions)
Figure 72. Italy RNAi Technology Market Size 2026-2031 ($ millions)
Figure 73. Russia RNAi Technology Market Size 2026-2031 ($ millions)
Figure 74. Egypt RNAi Technology Market Size 2026-2031 ($ millions)
Figure 75. South Africa RNAi Technology Market Size 2026-2031 ($ millions)
Figure 76. Israel RNAi Technology Market Size 2026-2031 ($ millions)
Figure 77. Turkey RNAi Technology Market Size 2026-2031 ($ millions)
Figure 78. Global RNAi Technology Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global RNAi Technology Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries RNAi Technology Market Size 2026-2031 ($ millions)